Literature DB >> 19805767

In the clinic. Community-acquired pneumonia.

Michael Niederman.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19805767     DOI： 10.7326/0003-4819-151-7-200910060-01004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  The Viriato study: update on antimicrobial resistance of microbial pathogens responsible for community-acquired respiratory tract infections in Portugal.

Authors:  José Melo-Cristino; Letícia Santos; Catarina Silva-Costa; Ana Friães; Marcos D Pinho; Mário Ramirez
Journal:  Paediatr Drugs       Date:  2010-06-29       Impact factor: 3.022

2.  Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics.

Authors:  Dean T Eurich; Sumit R Majumdar; Thomas J Marrie
Journal:  BMC Infect Dis       Date:  2012-06-18       Impact factor: 3.090

3.  Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study.

Authors:  Andrew F Shorr; Marya D Zilberberg; Jason Kan; Justin Hoffman; Scott T Micek; Marin H Kollef
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

4.  Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis.

Authors:  Gregory Hess; Jerrold W Hill; Monika K Raut; Alan C Fisher; Samir Mody; Jeff R Schein; Chi-Chang Chen
Journal:  Adv Ther       Date:  2010-08-26       Impact factor: 3.845

5.  Inpatient treatment of community-acquired pneumonias with integrative medicine.

Authors:  Ulrich Geyer; Klas Diederich; Maria Kusserow; Andreas Laubersheimer; Klaus Kramer
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-22       Impact factor: 2.629

6.  Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey.

Authors:  Sadeq A Quraishi; Edward A Bittner; Kenneth B Christopher; Carlos A Camargo
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.